Paper Details

  1. Home
  2. Paper Details

Effect of disease-modifying anti-rheumatic drugs in osteoarthritis: A meta-analysis.

Author: MathieuSylvain, SellamJérémie, SoubrierMartin, TournadreAnne

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Osteoarthritis (OA) involves inflammation, and while medications used for rheumatoid arthritis (DMARDs) might be helpful for OA, research has been inconsistent. This meta-analysis aimed to analyze existing studies to determine the overall effect of DMARDs (including methotrexate, hydroxychloroquine, TNF inhibitors, and IL-1 inhibitors) on OA.
Paper Details　
Original Abstract of the Article :
Osteoarthritis (OA) displays features of systemic and local inflammation, suggesting that DMARDs used in rheumatoid arthritis could potentially also be effective in OA. However, studies of the effects of DMARDs in OA have yielded conflicting data, and have been insufficiently large to draw conclusio...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jbspin.2022.105444

データ提供：米国国立医学図書館（NLM）

Exploring the Potential of DMARDs for Osteoarthritis Treatment

Osteoarthritis (OA), a degenerative joint disease, is a common ailment that can significantly impact mobility and quality of life. This study investigates the potential role of disease-modifying anti-rheumatic drugs (DMARDs), traditionally used for rheumatoid arthritis, in the treatment of OA. The research examines the evidence for DMARDs, such as methotrexate, hydroxychloroquine, TNF, and IL-1 inhibitors, in managing OA symptoms and improving outcomes.

Navigating the Desert of OA Treatment

While DMARDs are often effective for rheumatoid arthritis, their role in OA remains less clear. This study aims to shed light on the potential benefits of DMARDs for OA, synthesizing existing research and analyzing the effectiveness of different DMARDs. The study's findings will help to guide clinical decision-making and inform future research on OA treatment.

Seeking More Effective Treatments

This research highlights the need for continued exploration into the potential of DMARDs for OA management. While the evidence remains inconclusive, the study's findings suggest a potential avenue for developing more effective treatment approaches for OA. As we traverse the desert of OA research, we strive to discover new oases of relief for those affected by this debilitating condition.

Dr.Camel's Conclusion

The desert of OA can be a difficult journey, with limited treatment options. This study explores the potential of repurposing medications used for other conditions, such as rheumatoid arthritis. While the research offers promising insights, further exploration is needed to fully understand the role of DMARDs in OA. Like a camel seeking a safe passage through the desert, we must continue to explore innovative treatments and improve the lives of those living with OA.

Date :
  1. Date Completed 2022-11-23
  2. Date Revised 2023-03-16
Further Info :

Pubmed ID

35908643

DOI: Digital Object Identifier

10.1016/j.jbspin.2022.105444

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.